Interview: Tomer Feffer, CEO Bayer Scandinavia »We want to invest more in the Nordic region«
This week, the largest European partnering conference of the year, BIO-Europe, took place. This year's edition was held in Copenhagen with over 4000 industry representatives and more than 2000 companies from over 60 countries. BioStock was of course there and, among other things, got to talk to the relatively new CEO of Bayer Scandinavia, Tomer Feffer, about the company's conference activities, partnering strategies and his view of the Nordic life science scene. See the interview below!
Notes
Q-linea signs agreement with American trauma center
Diagonal Bio collaborates with SVA for coronavirus testing
SenzaGen secures order of SEK 1,3 million
Egetis carries out a directed share issue of SEK 183 million
Asker Healthcare acquires British Novus Med
NEWSLETTER
NEWS
Life science shows selective strength in the M&A recovery
Curasight reinforces the value of uTRACE with new US patent
China as a key global player – insights from BioStock's expert panel
Upcoming events!
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
MedTech Summit 2026
A new, much-needed MedTech forum in one of Europe's leading life science clusters. As the first event of its kind...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
Is Nordic life science on sale?
Springtime for biotech – the thaw has begun
